Gara Jalqabaatti › Infeekshinii Adenoviridae › Ohio
Qorannoo klinikaalii Infeekshinii Adenoviridae Ohio keessatti
Qorannoo 7 Infeekshinii Adenoviridae f Ohio keessatti hirmaatuu jiru.
Magaalota Ohio keessatti
Takkalaa qorannoo (Ingiliffa)
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07544589Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 85 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03665675Third Party Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 2
2 Days · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02532452Donor-Derived Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 1/2
4 Weeks · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02048332A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 3
2 Months · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07387367Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- Nationwide Children's Hosptial, Columbus
Namoota walitti qabaa jiraSadarkaa 2
1 Month – 79 Years · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT03266627Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 13-Cam-2025 · NCT04722029Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.